Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)
- 30 November 1999
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 181 (5), S39-S44
- https://doi.org/10.1016/s0002-9378(99)70362-5
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cyclesContraception, 1997
- A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and toleranceContraception, 1997
- A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μgContraception, 1997
- Low-Dose Combination Oral Contraceptives: A Controlled Clinical Study of Three Different Norgestrel-Ethinyl Estradiol RatiosFertility and Sterility, 1977
- STATISTICAL EVALUATION OF CONTRACEPTIVE METHODSClinical Obstetrics and Gynecology, 1974